Table 1.
Patient Characteristic | Full Sample (N=312) | Baseline Radiation Therapy Use | p | ||||
---|---|---|---|---|---|---|---|
Yes (N=24) | No (N=288) | ||||||
Continuous | mean | SD | mean | SD | mean | SD | |
Age in years | 58.6 | 12.6 | 61.0 | 14.1 | 58.4 | 12.5 | 0.333 |
Education in years | 12.4 | 4.0 | 11.5 | 3.6 | 12.4 | 4.1 | 0.295 |
Charlson Comorbidity Index | 8.6 | 2.6 | 8.8 | 2.5 | 8.6 | 2.6 | 0.667 |
Performance Status (ECOG) Score | 1.8 | 0.9 | 2.0 | 0.8 | 1.8 | 0.9 | 0.295 |
Categorical | n | % | n | % | n | % | p |
| |||||||
Gender, male | 171 | 54.8% | 14 | 58.3% | 157 | 54.5% | 0.718 |
Race/ethnicity | |||||||
White | 192 | 61.5% | 15 | 62.5% | 177 | 61.5% | 0.953 |
Black | 64 | 20.5% | 5 | 20.8% | 59 | 20.5% | |
Hispanic | 52 | 16.7% | 4 | 16.7% | 48 | 16.7% | |
Other | 4 | 1.3% | 0 | 0.0% | 4 | 1.4% | |
Married | 162 | 52.8% | 11 | 50.0% | 151 | 53.0% | 0.787 |
Health Insurance | 165 | 54.5% | 11 | 47.8% | 154 | 55.0% | 0.507 |
Recruitment Site | |||||||
Yale, Simmons, DFCI | 90 | 28.8% | 4 | 16.7% | 86 | 29.9% | 0.260 |
West Haven VA, Parkland | 162 | 51.9% | 13 | 54.2% | 149 | 51.7% | |
NH Oncology-Hematology | 60 | 19.2% | 7 | 29.2% | 53 | 18.4% | |
Cancer Diagnosis | |||||||
Lung | 72 | 23.1% | 9 | 37.5% | 63 | 21.9% | 0.219 |
Colon | 40 | 12.8% | 0 | 0.0% | 40 | 13.9% | |
Pancreatic | 23 | 7.4% | 1 | 4.2% | 22 | 7.6% | |
Other Gastrointestinal | 38 | 12.2% | 4 | 16.7% | 34 | 11.8% | |
Breast | 42 | 13.5% | 2 | 8.3% | 40 | 13.9% | |
Other | 97 | 31.1% | 8 | 33.3% | 89 | 30.9% | |
Cytotoxic Chemotherapy Use, Yes | 158 | 50.6% | 10 | 41.7% | 148 | 51.4% | 0.360 |
Variables missing data: Charlson (1), Married (5), Health Insurance (9)